scholarly article | Q13442814 |
P356 | DOI | 10.3109/1354750X.2012.657246 |
P698 | PubMed publication ID | 22356305 |
P2093 | author name string | B Kevin Park | |
Daniel J Antoine | |||
Jack W Sharkey | |||
P2860 | cites work | MicroRNAs identified in highly purified liver-derived mitochondria may play a role in apoptosis | Q34910425 |
A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer | Q34976475 | ||
MicroRNAs | Q37095827 | ||
The DNA/RNA-binding protein, translin, binds microRNA122a and increases its in vivo stability | Q39970123 | ||
Changes of micro-RNA expression in rat liver treated by acetaminophen or carbon tetrachloride--regulating role of micro-RNA for RNA expression | Q40061081 | ||
Drug-induced nephrotoxicity | Q41484994 | ||
Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). | Q41875540 | ||
MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
Circulating microRNAs, potential biomarkers for drug-induced liver injury | Q24656209 | ||
Micro-RNAs: small is plentiful | Q24672426 | ||
MicroRNA signatures in liver diseases | Q27488310 | ||
Prediction of mammalian microRNA targets | Q27860498 | ||
Identification of tissue-specific microRNAs from mouse | Q27860892 | ||
MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA | Q27861124 | ||
Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury | Q30484251 | ||
Differential regulation of microRNA stability | Q33799078 | ||
miR-122, a paradigm for the role of microRNAs in the liver | Q34010052 | ||
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. | Q34786558 | ||
P433 | issue | 3 | |
P921 | main subject | biomarker | Q864574 |
P304 | page(s) | 231-239 | |
P577 | publication date | 2012-02-22 | |
P1433 | published in | Biomarkers | Q4915076 |
P1476 | title | Validation of the isolation and quantification of kidney enriched miRNAs for use as biomarkers. | |
P478 | volume | 17 |
Q38027975 | Analysis of urinary microRNAs in chronic kidney disease. |
Q64965992 | Bariatric Surgery Modulates Urinary Levels of MicroRNAs Involved in the Regulation of Renal Function. |
Q58614676 | Biogenesis, Stabilization, and Transport of microRNAs in Kidney Health and Disease |
Q61451168 | Changes in Blood microRNA Expression and Early Metabolic Responsiveness 21 Days Following Bariatric Surgery |
Q26744741 | Clinical Application of Human Urinary Extracellular Vesicles in Kidney and Urologic Diseases |
Q34412383 | Determination of reference microRNAs for relative quantification in porcine tissues |
Q41147716 | Identification of reference microRNAs for quantitative expression analysis in porcine peripheral blood mononuclear cells treated with polyinosinic-polycytidylic acid |
Q55093828 | Improved physiology and metabolic flux after Roux-en-Y gastric bypass is associated with temporal changes in the circulating microRNAome: a longitudinal study in humans. |
Q37317156 | Isolation and quantification of microRNAs from urinary exosomes/microvesicles for biomarker discovery |
Q37377169 | MicroRNA Transcriptome of Poly I:C-Stimulated Peripheral Blood Mononuclear Cells Reveals Evidence for MicroRNAs in Regulating Host Response to RNA Viruses in Pigs |
Q26766102 | MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy |
Q38050081 | MicroRNAs, transforming growth factor beta-1, and tissue fibrosis. |
Q38753644 | Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon? |
Q38268801 | The emerging role of extracellular vesicles as biomarkers for urogenital cancers. |
Q38058047 | Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signalling |
Q34062884 | miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle |
Q37629026 | miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export |
Q38187448 | miRNAs and their application in drug-induced liver injury |